Teriparatide biosimilar (Pfenex)

特立帕肽生物类似药（Pfenex）

Report date: 2022/01/17 12:14:22

Base Information

Drug NameTeriparatide biosimilar (Pfenex)
Drug Alias Name特立帕肽生物仿制药（Pfenex）BonsityQutavinarhPTH (1-34) (Pfenex)PF-708
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionParathyroid hormone replacements
TargetsParathyroid hormone receptor
Therapy Area/IndicationsGlucocorticoid-induced osteoporosisOsteoporosis, PostmenopausalOsteoporosis
Global Approved IndicationsGlucocorticoid-induced osteoporosisOsteoporosis, PostmenopausalOsteoporosis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2019/10/04
Country/TerritoryUnited StatesEUMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaIND
Originator CompaniesPfenex Biopharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesChina Nt Pharma Group Company LtdKamadaAlvogen +[4] 
Inactive CompaniesPfenex IncEurogenerics
Active IndicationsGlucocorticoid-induced osteoporosisOsteoporosis, PostmenopausalOsteoporosis
Inactive IndicationsN/A

Other Information

ATC CodeH05AA02
Related LinksN/A